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Introduction
Retinal vein occlusion (RVO) is recognized as the second 
most common vascular disorder after diabetic retinopathy.1,2 
There are three distinct types of RVO: branch retinal vein 
occlusion (BRVO), central retinal vein occlusion (CRVO), 
and hemiretinal vein occlusion, which is an anatomical variant 
of CRVO. Central retinal vein occlusion can pose a major 
threat to vision through the potential sequelae of macular 
edema, retinal ischemia, retinal neovascularization, secondary 
vitreous hemorrhage, fibrous tissue formation, and secondary 
neovascular glaucoma. Although CRVO has been recognized 
as a disease entity for over 150 years, the classification, 
pathogenesis and management of the condition have remained 
controversial.3
The classic presentation of an acute CRVO includes 
pronounced dilation and tortuosity of retinal veins, retinal 
hemorrhages in all quadrants accompanied by extensive retinal 
edema, cotton-wool spots and optic disc swelling.4 As a CRVO 
affects the main venous outflow trunk, the entire venous system 
of the retina can become involved. One must also consider 
that in CRVO a patient may have complete obstruction of 
the central retinal vein but have well-developed collateral 
venous channels, such as in the case presented, and manifest 
only minimal funduscopic changes of venous occlusion. The 
diagnosis becomes less obvious if the presentation is of either 
an impending CRVO, less severe CRVO, or if the patient is late 
in the course of the disease where the dramatic acute findings 
have resolved over time. In the cases of either an impending 
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Central retinal vein occlusion (CRVO) may present with varied clinical manifestations, ranging from mild 
blurred vision and scattered retinal hemorrhages to severe vision loss, optic nerve swelling, pronounced 
retinal hemorrhages, collateral retinal vessel formation and neovascularization. Impending CRVO, also 
known as partial CRVO, is a relatively poorly-defined sub-classification of the CRVO condition. Those 
affected are either asymptomatic or may complain of mild, often transient episodes of blurring of vision 
and present with venous dilation and tortuosity but only a few widely scattered flame-shaped retinal 
hemorrhages. As an impending CRVO may be the prodromal phase of an acute CRVO, this diagnosis 
requires careful monitoring of the patient for progression. The following case outlines the differential 
diagnosis, sequelae and inter-professional management of an impending central retinal venous occlusion.
Résumé
L’occlusion de la veine rétinienne centrale (OVRC) peut produire divers symptômes cliniques variant de la 
vision floue légère et des hémorragies rétiniennes diffuses jusqu’à une perte de vision sévère, l’œdème du 
nerf optique, des hémorragies rétiniennes prononcées, l’apparition de vaisseaux rétiniens collatéraux et une 
néovascularisation. L’OVRC imminente, aussi appelée OVRC partielle ou bénigne, est une sous-catégorie 
relativement mal définie de l’OVRC. Les personnes atteintes sont asymptomatiques ou peuvent se plaindre 
d’épisodes bénins, souvent transitoires, de vision floue et présenter une dilatation et une tortuosité des 
vaisseaux sanguins, mais seulement quelques hémorragies rétiniennes très dispersées et en flammèches. 
Comme une OVRC imminente peut constituer la phase prodromique d’une OVRC aiguë, le diagnostic 
oblige à suivre attentivement l’évolution du problème chez le patient. Le cas qui suit décrit le diagnostic 
différentiel, les séquelles et la prise en charge interprofessionnelle d’une occlusion imminente de la veine 
rétinienne centrale.
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CRVO or mild CRVO the presenting signs may consist of only 
tortuous, dilated vasculature, disc hyperemia and swelling 
and a few scattered hemorrhages. These similarities make 
distinguishing a mild CRVO from an impending CRVO 
difficult; monitoring for change over time is required as 
these conditions may resolve without sequelae, as in the case 
presented, or an impending CRVO can progress to an acute 
CRVO requiring treatment. 
Case Report
A 49-year-old male presented to a primary care optometry 
clinic with episodes of blurred vision in the left eye, each lasting 
12 hours. The most recent episode was the night prior and was 
improving at the time of assessment. The patient stated he was 
anemic with a normal erythrocyte sedimentation rate, and that 
blood glucose and HbA1C as recently assessed by his physician 
were at the high end of normal. He was taking no medications. 
Blood pressure measured in office was 130/98 mmHg.
Best-corrected acuities were 20/15 in each eye; however, 
a 4 x 6 area of cloudy vision was noted superior-temporal 
to fixation on the Amsler grid for the left eye. Colour 
vision testing was normal and there was no relative afferent 
pupillary defect in either eye. Slit lamp examination of the 
anterior segment was unremarkable in each eye. Goldmann 
intraocular pressures were equal in each eye at 17 mmHg at 
1:00pm. A Humphrey visual field (30-2 SITA Standard) was 
unremarkable in each eye. A dilated fundus exam revealed 
bilateral arteriolar attenuation. In the left eye, moderate 
swelling of the superior aspect of the optic nerve and venous 
dilation was noted. A tortuous optociliary shunt vessel was also 
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Figure 1. Fundus images at initial presentation of the right (A) and left (B) eyes. Note the decreased 
arteriolar caliber in the right eye, likely indicative of systemic hypertension. In the left eye there is disc 
swelling secondary to the impending occlusion, venous dilation and an optociliary shunt vessel. Note 
the multiple scattered retinal hemorrhages, including a Roth spot, present in the left eye (C,D).
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present at the optic nerve of the left eye. Several dot-blot and 
retinal nerve fibre layer (RNFL) hemorrhages were noted in 
the macular area of the left eye, and one larger pale-centered 
RNFL hemorrhage (Roth spot) was located in the superior 
temporal arcades (Figure 1). In retrospect, a macular OCT 
to assess for the presence of macular edema would have been 
valuable but was not completed.
After the patient’s initial presentation, a referral was made 
to his primary care physician for a full physical examination, 
including CBC with differentials, blood glucose testing and an 
assessment for blood hypercoagulation. Given the presence of 
an optociliary shunt vessel, a CT scan of the head and orbits 
was performed to rule out any compressive lesion, including 
optic nerve sheath meningioma. The results of the above 
testing were unremarkable.
Over the following two months, the patient experienced 
two additional episodes of blurred vision in the left eye. One 
episode occurred one week after initial presentation and lasted 
24 hours, at which time the visual acuity was 20/20 in the 
right eye and 20/25 in the left eye. Funduscopic examination 
was unchanged from the initial presentation one week prior. 
Three weeks after initial presentation, there was significant 
resorption of the retinal hemorrhages in the left eye (Figure 2). 
The second episode of blurred vision occurred six 
weeks after initial presentation and lasted 3–4 days. Upon 
examination, the vision was 20/20 in each eye. Bilateral 
arteriolar attenuation was noted. In the left eye, there were 
scattered dot-blot hemorrhages throughout the retina, the 
tortuous optocilary shunt vessel remained engorged and 
venous dilation was present. Gonioscopy indicated that there 
was no neovascularization. During this episode, the patient 
noted a few neurological symptoms, including numbness in 
his right leg and foot. Inter-professional collaboration between 
the optometrist, primary care physician, ophthalmologist and 
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Figure 2. Fundus images 3 weeks after initial presentation in the right (A) and left (B) eyes. Note the significant improvement in the retinal hemorrhages in 
the left eye and resolution of the Roth spot (C).
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Figure 3. Images of the right (A) and left (B) fundus 
8 months after initial presentation. The  venous 
dilation has resolved, and the caliber of the 
optociliary shunt vessel is reduced. 
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neurologist allowed for co-ordinated medical care. A MRI study 
was not suggestive of multiple sclerosis and the neurological 
symptoms were attributed to a peripheral nerve injury and 
not demyelinating disease. A fluorescein angiography was 
requested but not performed by the ophthalmologist, who 
instead decided to monitor for progression.  A carotid Doppler 
study was undertaken to rule out carotid artery stenosis as the 
origin of the asymmetric retinopathy. A 24-hr ambulatory 
blood pressure to assess for excessive blood pressure 
variability was also completed. The results of these tests were 
unremarkable. A further fundus examination at 5 months 
was more typical of post-venous occlusion, given the venous 
collaterals noted at the left optic nerve. An evaluation eight 
months post-initial presentation demonstrated reduction in 
calibre of the left optociliary vessel and resolution of venous 
dilation (Figure 3). The patient remained symptom-free at his 
most recent exam, 16 months after initial presentation.
Discussion
The pathogenesis of CRVO is not fully understood, but 
it is currently thought that the condition is the result of a 
blockage of venous outflow, most likely at or posterior to the 
lamina cribrosa. It has been hypothesized that the occlusion 
forms as the result of the central retinal artery compressing 
the central retinal vein in the area where there is a common 
fibrous sleeve. This leads to a predisposition for endothelial 
damage and turbulent blood flow, as evidenced by fluorescein 
angiography.5 In advanced cases of CRVO, histopathologic 
studies have demonstrated a thrombus formation within 
the vessel whereby aggregated platelets mesh with cross-
linked fibrin protein. It is unknown why there is an affinity 
for thrombus formation in the central retinal vein at the 
location of the lamina cribrosa in CRVO, although  turbulent 
blood flow likely plays an important role.5 The variability in 
thrombus formation may explain the variety and severity of 
presentations of CRVO.4 Initial evaluation of a CRVO should 
include clinical examination and monitoring combined 
with fluorescein angiography to distinguish between a non-
ischemic and the more visually threatening ischemic CRVO. 
These two forms of CRVO and their respective treatment 
and prognosis are beyond the scope of this review, and are 
discussed elsewhere.5–7
Impending CRVO, also known as partial CRVO, is a 
relatively poorly-defined sub-classification of the condition 
which includes patients of a younger age than those typically 
presenting with CRVO, who are either asymptomatic or 
who may complain of mild, often transient episodes of 
blurring of vision.8 Most cases of impending CRVO have 
a good visual prognosis but some advance to complete 
CRVO, demonstrating that this condition has the potential 
for bidirectional progress.9 The fundus in impending CRVO 
usually demonstrates mild venous dilation and tortuosity and 
a few widely scattered flame-shaped retinal hemorrhages, as 
in the case presented. Some consider impending CRVO as a 
risk factor for the development of complete CRVO; however, 
there has been nothing definitive published regarding the 
natural history of impending CRVO.8,9 Furthermore, the 
patient presented in this report had developed an optociliary 
shunt which may have spared him from the more classic signs 
of CRVO.
As mentioned, impending CRVO may resolve or progress 
to complete obstruction; therefore treatment is aimed at 
preventing progression to complete occlusion by correcting 
any predisposing systemic conditions (most commonly 
including hypertension, diabetes, and/or hyperviscosity), 
avoiding dehydration, and lowering intraocular pressure 
(through topical and/or systemic treatment) to improve ocular 
perfusion. Some advocate antiplatelet agents, and in some 
circumstances (for example, in a monocular patient) it may be 
appropriate to consider other options such as anticoagulants, 
fibrinolytics or hemodilution.7,10 Others have suggested that 
the condition is self-limiting, making invasive investigation 
(including fluorescein angiography) and treatments (such 
as those listed above) with possible systemic complications 
unnecessary.11 Instead, the use of a multi-imaging approach 
including SD-OCT and fundus auto-fluorescence, can be used 
to detect the fern-like perivenular whitening changes that are 
characteristic in impending CRVO, and monitor for pro- or 
re-gression of this sign over time.12
Collateral vessel formation is a well-documented sequelae 
of CRVO. It has been suggested that 70% of optociliary shunt 
vessels are attributed to CRVOs.13 The shunt vessels typically 
develop 3-14 months after the occlusion. It has been reported 
that the presence of these anastomotic vessels following CRVO 
is associated with a decreased incidence of anterior segment 
neovascularization.14 Others have demonstrated that the 
presence of an optociliary vessel in non-ischemic CRVO is 
associated with shorter duration of macular edema.15
Optociliary vessels are collateral vessels of a retino-
choroidal origin that can be either congenital or acquired. 
Congenital optociliary shunt vessels direct blood from the 
choroid to the central retinal vein. In comparison, acquired 
optociliary vessels direct flow from central retinal vein to the 
choroid rerouting blood from an obstructed to an unobstructed 
vein. When the pressure in the central retinal vein becomes 
greater than that of the choroidal circulation, blood flow is 
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diverted and the optociliary vessel becomes visible. Other 
names for optociliary shunt vessels include optociliary veins, 
optociliary collaterals and perhaps most appropriate but not 
often used, retinochoroidal venous collaterals. In truth, the 
term optociliary shunt is a misnomer, as these vessels are 
retinochoroidal rather than optociliary, and are collateral 
vessels rather than shunts. For a review of collaterals, shunts 
and neovascularization, refer to Table 1. In cases of CRVO, 
the collateral vessel, if present, can be seen on the surface of 
the optic disc. If the occluded vessel becomes patent over time 
as the obstruction resolves, the collateral will recede, as was 
observed in this patient (see Figure 3).16 
Optociliary shunt vessels can also be present in optic nerve 
sheath meningiomas, which are associated with optic atrophy 
and progressive vision loss.16 Imaging via CT or MRI scan of the 
head and orbits can be performed to rule out this condition, as 
was completed in this patient. If not congenital, in addition to 
vascular occlusion and optic nerve sheath meningioma, other 
identified causes of acquired collateral vessel development 
include optic disc drusen, chronic papilledema, high myopia 
and diabetes.13,16–18
In summary, impending central retinal vein occlusions 
may be considered a sub-classification along the spectrum of 
CRVO. It is important to recognize that this condition may 
represent the prodromal signs of a CRVO, or may resolve 
without sequelae. In the presence of other confounding 
factors, such as an optociliary shunt vessel as seen in this 
case, it is important to rule out other diagnoses while also 
assessing for underlying risk factors for CRVO. As there is 
a strong association of CRVO with an underlying systemic 
condition (dyslipidemia, diabetes, systemic hypertension, 
cardiovascular disease), it is important to communicate with 
the patient’s primary care physician. The increased use of 
scanning laser ophthalmoscopy, SD-OCT, and fundus auto-
fluorescence may allow clinicians to monitor this condition 
in certain cases to avoid more invasive procedures, such as 
fluorescein angiography. 
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Vessel Type: Collateral Shunt Neovascularization
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appearance which leak
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